Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized parallel trial of topical insulin for dry eye disease
2021-006801-31Phase 4Active
- Sponsor
- Barbara Burgos-Blasco
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in dry eye syndrome (DED) (2 arms), sponsored by Barbara Burgos-Blasco. Primary endpoint: Absence of corneal staining. Started Mar 2022; status: active.
02
Drugs
human insulin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2021-006801-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006801-31.